The aim of this experiment was to detect the teratogenic effects of difloxacin in Wister Albino rats. Thirty pregnant rats were divided into 3 groups; group (1) behaved as control and received normal saline. Group (2) was administered difloxacin at a dose of 20 mg/kg b. wt and group (3) was administered difloxacin at a dose of 40 mg/kg b. wt orally once daily from 6 th to 15 th day of pregnancy. The study revealed no teratogenic effect at a dose of 20 mg/kg b. wt, while at a dose of 40 mg/kg b.wt has significant teratogenic effect showed by decrease in size, weight, length, retarded growth in fetuses, fetal resorption of treated groups, the incidences of skeletal & visceral abnormalities were increased in treated group (40 mg/kg b. wt). It could be concluded that. Administration of difloxacin during early stage of pregnancy and at high dose induce some fetal abnormalities.
INTRODUCTION
eratology, the study of abnormal prenatal development and congenital malformations induced by exogenous chemical or physical agents, is a growing area of medical research in the quest for the eradication of preventable birth defects. Birth defects are known to occur in huge numbers roughly seven to ten percent of all children require extensive medical care to diagnose or treat a birth defect, this compromise the quality of life for millions of people worldwide. Almost all therapeutic agents cross placental barrier and enter fetal circulation. Every agent given during pregnancy therefore has a tendency to produce some sort of structural abnormality in the neonate at birth until proved otherwise (Schlegel et al., 1991) . A birth defect or a congenital malformation is a structural abnormality of any type present at birth. It may be macroscopic or microscopic, on the surface or within the body (Moore, 1988) . During the past few decades, it has become increasingly evident that human and animal embryos are subjected to the toxic effects of many drugs, such as the use of some antibiotics in the treatment serious diseases occurring during pregnancy. Fluoroquinolones are one of the main classes of antimicrobials used in the treatment of many infections. (Amwayi and Otiang, 1997) . Fluoroquinolone antibiotics are commonly used to treat a variety of infections, including urinary tract, respiratory tract, gastrointestinal tract, skin, bone, and joint infections (Gurbay et al., 2002) . The popularity of fluoroquinolone antibiotics has increased because of their broad antimicrobial spectrum, multiple approved indications, and favorable pharmacokinetics (Mehlhorn and Brown, 2007) . Difloxacin is mainly used now for the treatment of urinary tract infections which have high incidence during pregnancy especially in the first trimester, and because difloxacin exert their effects via inhibition of nucleic acid synthesis, therefore this study was designed to evaluate the safety of difloxacin on embryonic development in rats. 
MATERIAL AND METHODS

Animals
Thirty female albino rats were aged 8-10 months, 200-250 gm b. wt., obtained from animal house colony of Faculty of Veterinary Medicine, Benha University. Rats were kept under hygienic conditions fed on standard balanced ration and water free from antimicrobials to withdraw any antibacterial residues. Female rats were examined periodically using vaginal smear technique to ensure that they were in regular estrous cycle. Two female in estrous phase was paired with a male of proven fertility in a separate cage. In the morning, vaginal smear was taken to verify day of pregnancy. Presence of spermatozoa in the obtained vaginal smear suspected pregnancy (Barcellona et al., 1977 
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Experimental design
Three groups contained ten pregnant female rats were used in this study as the following: Group (1): Ten pregnant rats were used as control group and received normal saline orally using stomach tube and sacrificed at 20 th day of pregnancy. Group (2): Ten pregnant rats were given therapeutic dose (20 mg/kg b.wt) of difloxacin orally using stomach tube from 6 th to 15 th day of pregnancy, rats were sacrificed at 20 th day of pregnancy to detect tetratogenic effects of difloxacin. Group (3): Ten pregnant rats were given high dose (40 mg/kg b.wt) of difloxacin orally using stomach tube from 6 th to 15 th day of pregnancy, rats were sacrificed at 20 th day of pregnancy to detect tetratogenic effects of difloxacin.
Teratological design
Ten pregnant female rats of tested groups were sacrificed at the 20 th day of gestation and dissected to examine the effect of difloxacin on fetal development by morphological, visceral and skeletal examinations.
Statistical analysis
Analysis of variance (ANOVA) using Duncan's multiple range test for variables was computed for different parameters. Differences between group means were considered significant at P < 0.05. 
RESULTS
Oral administration of difloxacin at a dose
DISCUSSION
The current investigation aimed to study teratogenic effect of difloxacin in rat's fetuses. Oral administration of difloxacin at adose of (20 mg/kg b.wt.) to pregnant rats didn't induce any teratogenic effects. Oral administration of difloxacin at adose of (40 mg/kg b.wt.) to pregnant rats induced marked and significant decrease in the number of fetuses/ mother when compared with that recorded value of the control group without any fetal death. This result was consistent with the data reported by Eteng et al., 2008) following administration of perfloxacin in rats. Difloxacin at a dose of (40 mg/kg b.wt.) resulted in marked decrease in number of viable fetus. This result was similar to those obtained by Tassinari et al. (1995) reported that, there was significant decrease in viable litter following administration of danofloxacin in pregnant rabbits. Difloxacin at a dose of (40 mg/kg b.wt.) resulted in marked increase in the number of resorbed fetuses either early or late. This result was similar to that reported by Becker et al. (1987) following administration of enrofloxacin to pregnant rabbit; Kesseddjian et al. 1989a and Tassinari et al., (1995) following administration of danofloxacin in mice and rabbits respectively. Aboubakr et al., (2014) proved that, norfloxacin was significantly decreased the number of viable feti, increased the number of resorbed feti and induced retardation in growth of viable feti when given to pregnant rats. Administration of difloxacin at a dose of (40 mg/kg b.wt.) to pregnant rats during the period of organogenesis produced significant decrease in both weight and length of fetuses. This result was consistent with several studies reported by Mobark (2010) and Siddiqui and Naqvi (2010).
Administration of difloxacin at dose of 40 mg/kg b.wt to pregnant rats during the period of organogenesis induced many fetal visceral abnormalities as diverticulum dilatation in the brain of fetuses. This result was consistent with those reported by Minta et al. (2005) following administration of enrofloxacin and ciprofloxacin to albino Wister rat. Oral administration of difloxacin (40 mg/kg b.wt.) to pregnant rats resulted in hypoplasia of thymus gland. This result was similar to that reported by Hussy et al. (1986) following administration of ciprofloxacin and ofloxacin in which a dose of 100 mg/ml which inhibit cell growth but 1000 mg/ml led to cell death. Administration of difloxacin at a dose of (40 mg/kg b.wt.) to pregnant rats produced cardiac hyperplasia which is a dosedependent. This result was also agreed with Stahlmann (1990) following administration of ofloxacin and ciprofloxacin to immature animals. Administration of difloxacin at a dose of (40 mg/kg b.wt.) to pregnant rats from 6 th to 15 th day of pregnancy induced pulmonary hypoplasia. Kim et al. (2000) reported that, after administration of DW-116 to pregnant rats showed significant visceral abnormalities. Pulmonary hypopIasia might be attributed to extensive distribution into lung and achieved higher concentration (Gilfillan et al., 1984) . Following administration of difloxacin to pregnant rats produced hepatomegaly and hypoplasia of one or both kidneys with unilateral or bilateral dilatation of renal pelvis. This result was similar to that reported by Schaefer et al. (1996) as there was about a 4.7% incidence of congenital malformation in live born children exposed to ciprofloxacin during the first trimester. Some fetal skeletal malformations were recorded such as impaired ossification of skull, absence of sternbrea, absence of digit's bone of fore and hind limb and absence of some metacarpal and metatarsal bone, reduction or absence of caudal vertebrae. This result agrees with that reported by many investigators as Kim et al (2000) , kim et al (2005); Lemus et al., (2009); Mobark (2010) and Siddiqui and Naqvi (2010).
CONCLUSIONS
it could be concluded that administration of difloxacin during pregnancy especially in early stage &at high doses could induce some fetal defects& abnormalities, so it is advisable to avoid using of this drug during pregnancy. 
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